Funded Tech Companies

Precision BioSciences

Precision BioSciences, based in Durham, received equity investments from private investors, Amgen Ventures and Brace Pharma.

Company Overview

Contact Information

Company Background Information

Overview

The Precision BioSciences (Nasdaq: DTIL) mission is to translate the world's most powerful genome editing technology into greatly needed products throughout the life sciences.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/3/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Matthew Kane

        

Chief Scientific Officer

Derek Jantz

        

Vice President

Clayton Beard

        

VP - Bus. Development

Drew Applefield

        

VP - Bus. Development

Michael Dombeck

        

VP - Engineering

Victor Bartsevich

        

VP - Finance

Abid Ansari

        

VP - Marketing

Heather King

        

VP - Operations

Sinu Bhandaru

        

VP - Regulatory Affairs

Marcia Gaido

        

Company Investors

• Amgen Ventures
• Brace Pharma
• DUMAC
• Alexandria Venture Investments
• Adage Capital Management
• Vivo Capital
• Cowen Capital Partners
• venBio (Robert Adelman)
• Agent Capital
• Osage Partners
• F-Prime Capital
• OCV Partners
• RA Capital
• Gilead Sciences
• Longevity Fund
• Pontifax AgTech
• Ridgeback Capital
• Cormorant Asset Management
• ArrowMark Partners
• Franklin Templeton

Browse more funded tech companies:

Precision Biopsy | Precision Compounding Pharmacy

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary